Growth Anticipated for Global Axial Spondyloarthritis (axSpA) Market Amid Rising Prevalence
The Business Research Company’s Anticipated for Global Axial Spondyloarthritis (axSpA) Global Market Report 2023 – Market Size, Trends, And Forecast 2023-2027
LONDON, GREATER LONDON, UK, October 20, 2023 /EINPresswire.com/ — The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
Increasing Prevalence Driving Market Expansion
The axial spondyloarthritis (axSpA) market is projected to reach $7.55 billion in 2027, demonstrating a CAGR of 8.1%. The escalating incidence of spondyloarthritis is expected to fuel the growth of the axial spondyloarthritis (axSpA) market. This chronic condition primarily affects the axial skeleton, including the spine and sacroiliac joints. Factors such as the aging population and spinal injuries resulting from minor accidents contribute to the rising prevalence. To manage pain, control inflammation, and enhance the quality of life for axSpA patients, various treatment options are available.
Innovative Product Development Shaping Market Trends
In the axial spondyloarthritis (axSpA) market, companies are emphasizing product innovations to strengthen their market presence. Notably, UCB SA received marketing authorization from the European Commission for BIMZELX (bimekizumab) in June 2023, marking a significant milestone in the treatment of adults with active axSpA.
Discover the market’s potential – [Sample Link]
https://www.thebusinessresearchcompany.com/sample.aspx?id=12590&type=smp
Key Players Powering Industry Advancements
Key players driving advancements in the axial spondyloarthritis (axSpA) market include Johnson and Johnson Private Limited, Pfizer Inc., F. Hoffmann-La Roche AG, and other prominent pharmaceutical companies.
Region-Wise Analysis
North America held the largest share in the axial spondyloarthritis (axSpA) market in 2022, while the Asia-Pacific region is poised for the most rapid growth during the forecast period. The report covers regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa.
Market Segmentation:
Types: Ankylosing spondylitis (AS), Non-radiographic axial spondyloarthritis (nr-axSpA)
• Commercialized Therapies: Anti-tumor Necrosis Factor Therapy (TNF), Anti-Interleukin Therapy (IL), Anti-Janus Kinase Therapy (JAK)
• Dosage Form: Tablets, Injections
• Treatment: Tumor necrosis factor (TNF) Alpha Inhibitors, Non-steroidal anti-inflammatory drugs (NSAID), Conventional Disease Modifying Anti-Rheumatic Drugs, Glucocorticoids, Interleukin Blockers
• End-Use: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacy Stores
Dive into the comprehensive report –
https://www.thebusinessresearchcompany.com/report/axial-spondyloarthritis-axspa-global-market-report
Axial Spondyloarthritis (axSpA) Global Market Report 2023 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Axial Spondyloarthritis (axSpA) Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on axial spondyloarthritis (axSpA) market size, axial spondyloarthritis (axSpA) market drivers and trends, axial spondyloarthritis (axSpA) market major players, competitors’ revenues, market positioning, and axial spondyloarthritis (axSpA) market growth across geographies. The axial spondyloarthritis (axSpA) market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Regenerative Medicine For Cartilage Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/regenerative-medicine-for-cartilage-global-market-report
Arthroscopy Devices And Equipment Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/arthroscopy-devices-and-equipment-global-market-report
Trauma Fixation Devices And Equipment Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/trauma-fixation-devices-and-equipment-global-market-report
About The Business Research Company?
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
